Repligen Corporation RGEN
$ 137.78
7.23%
Annual report 2023
added 11-18-2024
Country |
USA |
IPO year |
1986 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Anthony Hunt |
Employees in the company |
761 |
Shares |
55.7 K |
Market Cap[1] |
$ 7.68 M |
EBITDA (LTM) |
$ 41.9 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical instruments"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.